Nature Biotechnology reviews the state of play of senolytics
Nature Biotechnology - 12-Nov-2020In August, Unity announced that its lead drug candidate had failed to beat a placebo in reducing ...
Scott Lowe
Cancer biologist and chair of cancer biology & genetics program at Memorial Sloan Kettering Cancer Center in US
Dr. Lowe is a member and chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering Cancer Center, chairman of the Geoffrey Beene Cancer Research Center, and professor, Weill Cornell Graduate School of Medical Sciences.
Details last updated 18-Jun-2020
Scott Lowe News
Genetically engineered T cells can be used to target and kill senescent cells
Medical Xpress - 17-Jun-2020Tested successfully in mice with liver fibrosis and lung cancer
